Explore the latest in gastrointestinal cancer, including advances in management of esophageal, gastric, colorectal, and pancreatic malignancy.
This phase 2, multi-institutional clinical trial assesses whether patients with resected primary gastrointestinal stromal tumor receiving 5 years of adjuvant imatinib mesylate therapy have improved recurrence-free survival and overall survival compared with patients receiving a shorter duration of therapy in previous studies.
This survey study assesses patient attitudes and preferences about cessation of low-value colorectal cancer screening and their overall comfort using age, life expectancy calculators, and colorectal cancer risk calculators in helping make individualized screening decisions.
This systematic review and meta-analysis examines interventions used to increase the rates of colorectal cancer screening tests.
This Teachable Moment describes the case of a 58-year-old man with bilateral knee osteoarthritis who presented to the emergency department with 1 week of dizziness and intermittent dark stools.
This analysis of genomic data from The Cancer Genome Atlas and an Asian cohort investigates associations between MUC16 mutation, tumor mutation load, and survival in patients with gastric cancer.
This single-arm, 2-stage, phase 2 clinical trial assesses the safety and efficacy of intravenous gemcitabine plus nanoparticle albumin-bound–paclitaxel for treatment of adults with advanced cholangiocarcinoma.
This pooled analysis of the Nurses’ Health Study and the Health Professionals Follow-up Study examines the association between long-term use of aspirin and the development of hepatocellular carcinoma in adult men and women.
This Markov model study assesses the cost-effectiveness of capecitabine and bevacizumab maintenance therapy after induction chemotherapy for treatment of metastatic colorectal cancer.
This randomized clinical trial assesses the safest procedures after initial successful nonoperative treatment of periappendicular abscess by comparing treatment success and morbidity in patients receiving interval appendectomy with patients receiving nonsurgical follow-up with magnetic resonance imaging.
This multicenter, phase 2, single-arm trial assesses the activity of cetuximab plus irinotecan as third-line treatment for patients with RAS and BRAF wild-type metastatic colorectal cancer who were initially sensitive to and then resistant to first-line irinotecan- and cetuximab-based therapy.
This cohort study investigates possible mechanisms underlying primary resistance to immune checkpoint inhibitors of metastatic colorectal cancers displaying microsatellite instability or mismatch repair deficiency.
This single-arm study evaluates the role of fluorescent lymphography using near-infrared imaging as an intraoperative tool for achieving complete lymph node dissection and compares the number of lymph nodes retrieved with the use of near-infrared imaging and the number of lymph nodes retrieved without the use of near-infrared imaging.
This multicenter study investigates the risk factors, patterns, and outcomes of late recurrence after curative liver resection for hepatocellular carcinoma.
This cohort study of patients from the 5 Nordic countries examines whether gastroesophageal antireflux surgery is associated with decreased risk of esophageal adenocarcinoma and whether surgically and medically treated patients experience different outcomes.
This Special Communication discusses consensus recommendations regarding follow-up of fully resected, well-differentiated, or moderately differentiated gastroenteropancreatic neuroendocrine tumors.
This cohort study assesses the association of immunologic variables and survival in patients with resectable pancreatic ductal adenocarcinoma.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: